BioPharma Resources

Drug Trial Radar · NCT07701993

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

A Phase 3, Double-blind, Randomized, Placebo Controlled, 2-arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Injection in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (NEBULA-1)

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Title says "pivotal". Randomized with 1,740 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,740

Planned (sponsor's estimate)

Start

Jul 22, 2026

Primary completion

Jun 23, 2033

Study completion Aug 24, 2033

Sponsor

Lead sponsor
GlaxoSmithKlineGSK (GSK)
Sponsor type
Industry
First posted
Jul 14, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will investigate the safety and efficacy of efimosfermin alfa in participants with compensated cirrhosis due to MASH.

Conditions

  • Metabolic Dysfunction-associated Steatohepatitis

Interventions

  • Efimosfermin alfaDrug

    Efimosfermin alfa (subcutaneous injection) will be administered.

  • PlaceboDrug

    Placebo (subcutaneous injection) will be administered.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time from randomization to an adjudicated composite liver-related clinical outcomeTime frame: From Randomization (Day 1) to Week 356 (end of treatment)

Locations

37 sites in 2 countries. Site status is shown where the registry gives one.

  • GSK Investigational Site

    Little Rock, Arkansas · Recruiting

  • GSK Investigational Site

    Folsom, California · Recruiting

  • GSK Investigational Site

    Montclair, California · Recruiting

  • GSK Investigational Site

    Santa Maria, California · Recruiting

  • GSK Investigational Site

    Cape Coral, Florida · Recruiting

  • GSK Investigational Site

    Clermont, Florida · Recruiting

  • GSK Investigational Site

    Fort Myers, Florida · Recruiting

  • GSK Investigational Site

    Hialeah, Florida · Recruiting

  • GSK Investigational Site

    Homestead, Florida · Recruiting

  • GSK Investigational Site

    Kissimmee, Florida · Recruiting

  • GSK Investigational Site

    Lakeland, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Ocala, Florida · Recruiting

  • GSK Investigational Site

    University Park, Florida · Recruiting

  • GSK Investigational Site

    Glen Burnie, Maryland · Recruiting

  • GSK Investigational Site

    St Louis, Missouri · Recruiting

  • GSK Investigational Site

    East Syracuse, New York · Recruiting

  • GSK Investigational Site

    New York, New York · Recruiting

  • GSK Investigational Site

    Morehead City, North Carolina · Recruiting

  • GSK Investigational Site

    Westlake, Ohio · Recruiting

  • GSK Investigational Site

    Arlington, Texas · Recruiting

  • GSK Investigational Site

    Austin, Texas · Recruiting

  • GSK Investigational Site

    Austin, Texas · Recruiting

  • GSK Investigational Site

    Bellaire, Texas · Recruiting

  • GSK Investigational Site

    Dallas, Texas · Recruiting

  • GSK Investigational Site

    Humble, Texas · Recruiting

  • GSK Investigational Site

    San Antonio, Texas · Recruiting

  • GSK Investigational Site

    San Antonio, Texas · Recruiting

  • GSK Investigational Site

    Waco, Texas · Recruiting

  • GSK Investigational Site

    West Jordan, Utah · Recruiting

  • GSK Investigational Site

    Manassas, Virginia · Recruiting

  • GSK Investigational Site

    Seattle, Washington · Recruiting

  • GSK Investigational Site

    Kawasaki-shi, Japan · Recruiting

  • GSK Investigational Site

    Ōita, Japan · Recruiting

  • GSK Investigational Site

    Ōgaki, Gifu, Japan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.